Literature DB >> 15161606

Acidosis impairs insulin receptor substrate-1-associated phosphoinositide 3-kinase signaling in muscle cells: consequences on proteolysis.

Harold A Franch1, Sina Raissi, Xiaonan Wang, Bin Zheng, James L Bailey, S Russ Price.   

Abstract

Chronic acidosis is a stimulus for proteolysis in muscle in vivo, but the mechanism of this response is unknown. We tested the hypothesis that acidosis or TNF-alpha, a cytokine whose production increases in acidosis, regulates proteolysis by inhibiting insulin signaling through phosphoinositide 3-kinase (PI3K). In cultured L6 myotubes, acidified (pH 7.1) media did not accelerate the basal protein degradation rate, but it inhibited insulin's ability to suppress proteolysis. Insulin receptor substrate-1 (IRS-1)-associated PI3K activity was not altered in cells acidified for 10 min but was strongly inhibited in cells incubated at pH 7.1 for 24 h. Phosphorylation of Akt was also suppressed by acidification for 24 h. Acidification did not induce changes in IRS-1 abundance, insulin-stimulated IRS-1 tyrosine phosphorylation, or the amount of PI3K p85 regulatory subunit. In contrast to acidification, TNF-alpha suppressed proteolysis in the presence or absence of insulin but had no effect on IRS-1-associated PI3K activity. To establish that the PI3K pathway can regulate protein degradation in muscle, we measured proteolysis in cells after inhibition of PI3K activity with LY-294002 or infection with an adenovirus encoding a dominant negative PI3K p85alpha-subunit. Both approaches inhibited insulin-induced suppression of proteolysis to a degree similar to that seen with acidification. We conclude that acidosis accelerates protein degradation by impairing insulin signaling through PI3K in muscle cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15161606     DOI: 10.1152/ajprenal.00440.2003

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  25 in total

1.  Membrane depolarization is the trigger for PI3K/Akt activation and leads to the generation of ROS.

Authors:  Shampa Chatterjee; Elizabeth A Browning; NanKang Hong; Kris DeBolt; Elena M Sorokina; Weidong Liu; Morris J Birnbaum; Aron B Fisher
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-10-14       Impact factor: 4.733

2.  Fecal microbiota analysis of polycystic kidney disease patients according to renal function: A pilot study.

Authors:  Rabi Yacoub; Girish N Nadkarni; Daniel I McSkimming; Lee D Chaves; Sham Abyad; Mark A Bryniarski; Amanda M Honan; Shruthi A Thomas; Madan Gowda; John C He; Jaime Uribarri
Journal:  Exp Biol Med (Maywood)       Date:  2018-12-12

3.  Impaired skeletal muscle mitochondrial bioenergetics and physical performance in chronic kidney disease.

Authors:  Bryan Kestenbaum; Jorge Gamboa; Sophia Liu; Amir S Ali; Eric Shankland; Thomas Jue; Cecilia Giulivi; Lucas R Smith; Jonathan Himmelfarb; Ian H de Boer; Kevin Conley; Baback Roshanravan
Journal:  JCI Insight       Date:  2020-03-12

Review 4.  Molecular and biological pathways of skeletal muscle dysfunction in chronic obstructive pulmonary disease.

Authors:  Esther Barreiro; Joaquim Gea
Journal:  Chron Respir Dis       Date:  2016-04-06       Impact factor: 2.444

5.  XIAP reduces muscle proteolysis induced by CKD.

Authors:  Junping Hu; Jie Du; Liping Zhang; S Russ Price; Janet D Klein; Xiaonan H Wang
Journal:  J Am Soc Nephrol       Date:  2010-04-29       Impact factor: 10.121

Review 6.  An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease.

Authors:  François Maltais; Marc Decramer; Richard Casaburi; Esther Barreiro; Yan Burelle; Richard Debigaré; P N Richard Dekhuijzen; Frits Franssen; Ghislaine Gayan-Ramirez; Joaquim Gea; Harry R Gosker; Rik Gosselink; Maurice Hayot; Sabah N A Hussain; Wim Janssens; Micheal I Polkey; Josep Roca; Didier Saey; Annemie M W J Schols; Martijn A Spruit; Michael Steiner; Tanja Taivassalo; Thierry Troosters; Ioannis Vogiatzis; Peter D Wagner
Journal:  Am J Respir Crit Care Med       Date:  2014-05-01       Impact factor: 21.405

7.  FOXO3a mediates signaling crosstalk that coordinates ubiquitin and atrogin-1/MAFbx expression during glucocorticoid-induced skeletal muscle atrophy.

Authors:  Bin Zheng; Sakae Ohkawa; Haiyan Li; Tiffany K Roberts-Wilson; S Russ Price
Journal:  FASEB J       Date:  2010-04-06       Impact factor: 5.191

8.  Combined walking exercise and alkali therapy in patients with CKD4-5 regulates intramuscular free amino acid pools and ubiquitin E3 ligase expression.

Authors:  Emma L Watson; George C Kosmadakis; Alice C Smith; Joao L Viana; Jeremy R Brown; Karen Molyneux; Izabella Z A Pawluczyk; Michael Mulheran; Nicolette C Bishop; Susan Shirreffs; Ronald J Maughan; Paul J Owen; Stephen G John; Christopher W McIntyre; John Feehally; Alan Bevington
Journal:  Eur J Appl Physiol       Date:  2013-04-17       Impact factor: 3.078

9.  Regulation of caspase-3 activity by insulin in skeletal muscle cells involves both PI3-kinase and MEK-1/2.

Authors:  Yongmei Gao; Ronald Ordas; Janet D Klein; S Russ Price
Journal:  J Appl Physiol (1985)       Date:  2008-10-02

10.  Association of serum bicarbonate levels with mortality in patients with non-dialysis-dependent CKD.

Authors:  Csaba P Kovesdy; John E Anderson; Kamyar Kalantar-Zadeh
Journal:  Nephrol Dial Transplant       Date:  2008-11-17       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.